Flavoured water consumption alters pharmacokinetic parameters and increases exposure of erlotinib and gefitinib in a preclinical study using Wistar rats

BACKGROUND: Erlotinib (ERL) and Gefitinib (GEF) are considered first line therapy for the management of non-small cell lung carcinoma (NSCLC). Like other tyrosine kinase inhibitors (TKIs), ERL and GEF are mainly metabolized by the cytochrome P450 (CYP450) CYP3A4 isoform and are substrates for transp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PeerJ
Main Authors: Almomen, Aliyah, Maher, Hadir M., Alzoman, Nourah Z., Shehata, Shereen M., Alsubaie, Amal
Formato: Artigo
Idioma:Inglês
Publicado em: PeerJ Inc. 2020
Assuntos:
Toxicology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7518156/
https://ncbi.nlm.nih.gov/pubmed/33024629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.9881
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados